Top 10 List
All 10 filings cover the third quarter of 2026, and in each case the registrant is the same organization as the client.
1. Eli Lilly & Co. — reported $2,590,000. Issues: pharma IP protection and trade (USMCA, Special 301, tariffs), drug pricing and Inflation Reduction Act implementation, 340B, and tax policy.
2. General Atomics — reported $2,160,000. No issue text disclosed.
3. Palantir Technologies Inc. — reported $2,110,000. No issue text disclosed.
4. Select Medical Holdings Corp. — reported $1,900,000. No issue text disclosed.
5. Securities Industry and Financial Markets Association — reported $1,810,000. Issues: the Investing in Our Communities Act, the GENIUS Act (Public Law 119-27), and the Retirement Fairness for Charities and Educational Institutions Act.
6. Airlines for America Inc. — reported $1,100,700. No issue text disclosed.
7. America's Credit Unions — reported $1,060,000. Issues: protecting the credit union tax exemption, reducing the National Credit Union Administration (NCUA) budget, and streamlining Small Business Administration (SBA) lending program participation.
8. American Clinical Laboratory Association — reported $850,000. No issue text disclosed.
9. Aerospace Industries Association of America Inc. — reported $800,000. Issues: FY2026-27 budget and appropriations, Federal Aviation Administration (FAA) and aviation legislation, space and NASA policy, the FY2027 National Defense Authorization Act (NDAA), export controls and foreign military sales, and SBIR/STTR programs.
10. Airports Council International - North America — reported $731,939. No issue text disclosed.
Access the Legis1 platform for comprehensive political news, data, and insights.
Spot something wrong? Report an issue with this article
